Kasowitz, on behalf of real estate developer Rotem Rosen, has defeated a motion to dismiss in a lawsuit against his former business partner Alex Sapir and, in a separate lawsuit, obtained dismissal of misappropriation of trade secrets and other claims brought by Mr. Sapir against Mr. Rosen....
Found It.
Showing 957 Results For
“”
Kasowitz filed an amicus curiae brief in the Second Circuit Court of Appeals, on behalf of Up-Stand, an organization advocating improving mass transit accessibility for pregnant women and families, in support of a class action against the Metropolitan Transportation Authority and New York City Trans...
In a pathbreaking decision under the longstanding and well-established, but rarely invoked, constitutional tolling doctrine, Judge Sharon Gleason, U.S. District Court for Alaska, on September 28, 2021, granted Kasowitz clients Alaskan Reefer Management (ARM) and Kloosterboer International Forwarding...
Kasowitz secured another victory for private equity firm Saw Mill Capital in defeating an appeal brought by former employee John Shaia....
Kasowitz secured an appellate victory on behalf of XP Investments US LLC, a U.S.-based affiliate of one of Brazil’s largest asset managers, and its former Chief Executive Officer. ...
Kasowitz, in partnership with The Legal Aid Society of New York, has obtained two victories for pro bono clients seeking unemployment benefits....
Kasowitz represented a leading real estate investment company in the sale of a Class-A office center located in Scottsdale, Arizona to a California-based real estate investment and services group....
Kasowitz has obtained an immigration court order granting asylum to a refugee from Chad. ...
Kasowitz, on behalf of asset management funds Hudson Transport Real Asset Master Fund and CarVal Investors entities holding $14 million-plus in Class B certificates issued by Norwegian Air Shuttle in connection with the financing of 10 Norwegian Air Shuttle ASA aircraft in 2016, defeated motions to ...
Kasowitz, on behalf of Teva Pharmaceuticals, the world’s largest generic drug manufacturer, and its directors and officers, negotiated with class counsel a $420 million all-cash settlement to resolve one of the nation’s largest pending securities class actions....
957 results / 96 pages